These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 29353121)

  • 41. Association of
    La Joie R; Visani AV; Lesman-Segev OH; Baker SL; Edwards L; Iaccarino L; Soleimani-Meigooni DN; Mellinger T; Janabi M; Miller ZA; Perry DC; Pham J; Strom A; Gorno-Tempini ML; Rosen HJ; Miller BL; Jagust WJ; Rabinovici GD
    Neurology; 2021 Feb; 96(5):e650-e661. PubMed ID: 33262228
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical and imaging progression over 10 years in a patient with primary progressive apraxia of speech and autopsy-confirmed corticobasal degeneration.
    Tetzloff KA; Duffy JR; Strand EA; Machulda MM; Boland SM; Utianski RL; Botha H; Senjem ML; Schwarz CG; Josephs KA; Whitwell JL
    Neurocase; 2018 Apr; 24(2):111-120. PubMed ID: 29799310
    [TBL] [Abstract][Full Text] [Related]  

  • 43. S-[18F]THK-5117-PET and [11C]PIB-PET Imaging in Idiopathic Normal Pressure Hydrocephalus in Relation to Confirmed Amyloid-β Plaques and Tau in Brain Biopsies.
    Leinonen V; Rauramaa T; Johansson J; Bottelbergs A; Tesseur I; van der Ark P; Pemberton D; Koivisto AM; Jääskeläinen JE; Hiltunen M; Herukka SK; Blennow K; Zetterberg H; Jokinen P; Rokka J; Helin S; Haaparanta-Solin M; Solin O; Okamura N; Kolb HC; Rinne JO
    J Alzheimers Dis; 2018; 64(1):171-179. PubMed ID: 29865068
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [
    Lagarde J; Olivieri P; Caillé F; Gervais P; Baron JC; Bottlaender M; Sarazin M
    J Neurol; 2019 Dec; 266(12):3087-3097. PubMed ID: 31535269
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Flortaucipir tau PET imaging in semantic variant primary progressive aphasia.
    Makaretz SJ; Quimby M; Collins J; Makris N; McGinnis S; Schultz A; Vasdev N; Johnson KA; Dickerson BC
    J Neurol Neurosurg Psychiatry; 2018 Oct; 89(10):1024-1031. PubMed ID: 28986472
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 18F-AV-1451 positron emission tomography in neuropathological substrates of corticobasal syndrome.
    Goodheart AE; Locascio JJ; Samore WR; Collins JA; Brickhouse M; Schultz A; Touroutoglou A; Johnson KA; Frosch MP; Growdon JH; Dickerson BC; Gomperts SN
    Brain; 2021 Feb; 144(1):266-277. PubMed ID: 33578418
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multimodal
    Pascual B; Funk Q; Zanotti-Fregonara P; Pal N; Rockers E; Yu M; Spann B; Román GC; Schulz PE; Karmonik C; Appel SH; Masdeu JC
    J Nucl Med; 2020 Feb; 61(2):263-269. PubMed ID: 31350322
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Distinct patterns of amyloid-dependent tau accumulation in Lewy body diseases.
    Lee SH; Cho H; Choi JY; Lee JH; Ryu YH; Lee MS; Lyoo CH
    Mov Disord; 2018 Feb; 33(2):262-272. PubMed ID: 29168583
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Subtypes of progressive aphasia: application of the International Consensus Criteria and validation using β-amyloid imaging.
    Leyton CE; Villemagne VL; Savage S; Pike KE; Ballard KJ; Piguet O; Burrell JR; Rowe CC; Hodges JR
    Brain; 2011 Oct; 134(Pt 10):3030-43. PubMed ID: 21908392
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical dimensions along the non-fluent variant primary progressive aphasia spectrum.
    Illán-Gala I; Lorca-Puls DL; Tee BL; Ezzes Z; de Leon J; Miller ZA; Rubio-Guerra S; Santos-Santos M; Gómez-Andrés D; Grinberg LT; Spina S; Kramer JH; Wauters LD; Henry ML; Boxer AL; Rosen HJ; Miller BL; Seeley WW; Mandelli ML; Gorno-Tempini ML
    Brain; 2024 Apr; 147(4):1511-1525. PubMed ID: 37988272
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fluorodeoxyglucose F18 positron emission tomography in progressive apraxia of speech and primary progressive aphasia variants.
    Josephs KA; Duffy JR; Fossett TR; Strand EA; Claassen DO; Whitwell JL; Peller PJ
    Arch Neurol; 2010 May; 67(5):596-605. PubMed ID: 20457960
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages.
    Schwarz AJ; Yu P; Miller BB; Shcherbinin S; Dickson J; Navitsky M; Joshi AD; Devous MD; Mintun MS
    Brain; 2016 May; 139(Pt 5):1539-50. PubMed ID: 26936940
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Apraxia of speech and phonological errors in the diagnosis of nonfluent/agrammatic and logopenic variants of primary progressive aphasia.
    Croot K; Ballard K; Leyton CE; Hodges JR
    J Speech Lang Hear Res; 2012 Oct; 55(5):S1562-72. PubMed ID: 23033449
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An autoradiographic evaluation of AV-1451 Tau PET in dementia.
    Lowe VJ; Curran G; Fang P; Liesinger AM; Josephs KA; Parisi JE; Kantarci K; Boeve BF; Pandey MK; Bruinsma T; Knopman DS; Jones DT; Petrucelli L; Cook CN; Graff-Radford NR; Dickson DW; Petersen RC; Jack CR; Murray ME
    Acta Neuropathol Commun; 2016 Jun; 4(1):58. PubMed ID: 27296779
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metabolic and Structural Signatures of Speech and Language Impairment in Corticobasal Syndrome: A Multimodal PET/MRI Study.
    Parmera JB; de Almeida IJ; de Oliveira MCB; Silagi ML; de Godoi Carneiro C; Studart-Neto A; Ono CR; Reis Barbosa E; Nitrini R; Buchpiguel CA; Brucki SMD; Coutinho AM
    Front Neurol; 2021; 12():702052. PubMed ID: 34526958
    [No Abstract]   [Full Text] [Related]  

  • 56. Cross-Sectional and Longitudinal Assessment of Behavior in Primary Progressive Apraxia of Speech and Agrammatic Aphasia.
    Hokelekli FO; Duffy JR; Clark HM; Utianski RL; Botha H; Stierwalt JA; Strand EA; Machulda MM; Whitwell JL; Josephs KA
    Dement Geriatr Cogn Disord; 2022; 51(2):193-202. PubMed ID: 35526526
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Positron emission tomography imaging of tau pathology in progressive supranuclear palsy.
    Coakeley S; Cho SS; Koshimori Y; Rusjan P; Harris M; Ghadery C; Kim J; Lang AE; Wilson A; Houle S; Strafella AP
    J Cereb Blood Flow Metab; 2017 Sep; 37(9):3150-3160. PubMed ID: 28155586
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B.
    Leinonen V; Alafuzoff I; Aalto S; Suotunen T; Savolainen S; Någren K; Tapiola T; Pirttilä T; Rinne J; Jääskeläinen JE; Soininen H; Rinne JO
    Arch Neurol; 2008 Oct; 65(10):1304-9. PubMed ID: 18695050
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sub-classification of apraxia of speech in patients with cerebrovascular and neurodegenerative diseases.
    Takakura Y; Otsuki M; Sakai S; Tajima Y; Mito Y; Ogata A; Koshimizu S; Yoshino M; Uemori G; Takakura S; Nakagawa Y
    Brain Cogn; 2019 Mar; 130():1-10. PubMed ID: 30622034
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tau PET Imaging with [18F]PM-PBB3 in Frontotemporal Dementia with MAPT Mutation.
    Su Y; Fu J; Yu J; Zhao Q; Guan Y; Zuo C; Li M; Tan H; Cheng X
    J Alzheimers Dis; 2020; 76(1):149-157. PubMed ID: 32444551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.